VKTX vs. SPY
Compare and contrast key facts about Viking Therapeutics, Inc. (VKTX) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VKTX or SPY.
Correlation
The correlation between VKTX and SPY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VKTX vs. SPY - Performance Comparison
Key characteristics
VKTX:
-0.78
SPY:
0.50
VKTX:
-1.23
SPY:
0.88
VKTX:
0.86
SPY:
1.13
VKTX:
-0.83
SPY:
0.56
VKTX:
-1.48
SPY:
2.17
VKTX:
44.25%
SPY:
4.85%
VKTX:
84.02%
SPY:
20.02%
VKTX:
-90.41%
SPY:
-55.19%
VKTX:
-70.85%
SPY:
-7.65%
Returns By Period
In the year-to-date period, VKTX achieves a -31.54% return, which is significantly lower than SPY's -3.42% return. Both investments have delivered pretty close results over the past 10 years, with VKTX having a 11.87% annualized return and SPY not far ahead at 12.35%.
VKTX
-31.54%
19.26%
-59.77%
-65.65%
33.50%
11.87%
SPY
-3.42%
2.87%
-5.06%
9.87%
15.76%
12.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VKTX vs. SPY — Risk-Adjusted Performance Rank
VKTX
SPY
VKTX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VKTX vs. SPY - Dividend Comparison
VKTX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.27%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VKTX Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.27% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
VKTX vs. SPY - Drawdown Comparison
The maximum VKTX drawdown since its inception was -90.41%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for VKTX and SPY. For additional features, visit the drawdowns tool.
Volatility
VKTX vs. SPY - Volatility Comparison
Viking Therapeutics, Inc. (VKTX) has a higher volatility of 21.06% compared to SPDR S&P 500 ETF (SPY) at 7.48%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.